PubMed · 10813207
Progressive systemic sclerosis and the lung.
Abstract
Pulmonary manifestations of systemic sclerosis (scleroderma) are many. The mean survival in these patients is 78 +/- 17 months. Improved diagnostic techniques and better therapeutic options are essential to stem the tide of overwhelming mortality in patients with scleroderma lung disease.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
S Veeraraghavan, O P Sharma. 1998. Progressive systemic sclerosis and the lung.. https://doi.org/10.1097/00063198-199809000-00011
Cite the original work for its findings. Save a collection to share your selection of sources.